Medicure (MCUJF) Consolidated Net Income (2009 - 2026)
Medicure (MCUJF) recorded quarterly Consolidated Net Income of -$296057.5 in Q1 2026, up 95.72% quarter-over-quarter from -$6.9 million in Q4 2025, and up 38.79% on a YoY basis from -$213316.2 in Q1 2025.
Medicure (MCUJF) Consolidated Net Income (2009 - 2026) Analysis & Trends
Medicure's Consolidated Net Income history runs 18 years deep, the most recent figure standing at -$296057.5 for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 38.79% year-over-year to -$296057.5; the TTM figure through Mar 2026 stood at -$8.8 million (down 686.67% YoY), while the FY2025 annual figure was -$5.1 million, down 584.24% from the prior year.
- Consolidated Net Income was -$296057.5 for Q1 2026 at Medicure, up from -$6.9 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $4.0 million in Q4 2022 to a low of -$6.9 million in Q4 2025.
- Historically, Consolidated Net Income has averaged -$276958.2 across 5 years, with a median of $37847.8 in 2024.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income jumped 752.56% in 2024, then slumped 1648.95% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at $4.0 million in 2022, then tumbled by 130.02% to -$1.2 million in 2023, then jumped by 66.94% to -$395864.6 in 2024, then plunged by 1648.95% to -$6.9 million in 2025, then jumped by 95.72% to -$296057.5 in 2026.
- The last three Consolidated Net Income figures came in at -$296057.5 (Q1 2026), -$6.9 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Medicure | - | - | 2.57 Mn | -296,057.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -296,057.51 |
| Dec 31, 2025 | -6.92 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -567,266.02 |
| Mar 31, 2025 | -483,660.03 |
| Dec 31, 2024 | -395,864.57 |
| Sep 30, 2024 | 489,679.68 |
| Jun 30, 2024 | -728,947.13 |
| Mar 31, 2024 | 37,847.77 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | 57,436.65 |
| Jun 30, 2023 | 286,614.20 |
| Mar 31, 2023 | 224,867.70 |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 880,991.44 |
| Jun 30, 2022 | 552,175.82 |
| Mar 31, 2022 | 380,527.14 |
| Sep 30, 2021 | -787,259.63 |
| Jun 30, 2021 | 463,710.48 |
| Mar 31, 2021 | 828,023.88 |